Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration

Ch. Dittrich, G. Greim, Markus Borner, K. Weigang-Köhler, Holger Huisman, A. Amelsberg, Andreas Ehret, J. Wanders, Axel‐R. Hanauske, P. Fumoleau

European Journal of Cancer · 2002 · 71 citations · 7 references

Concepts

References

7